Skip to content

Twitter page opens in new window Linkedin page opens in new window Instagram page opens in new window

info@pharmaust.com+61 8 9202 6814

PharmAust (PAA)

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

January 9, PAA LUMC COVID-19 Research Update

210109_PAA_LUMC Update

Category: News and Announcements 2021By Richard Mollard January 8, 2021

Related posts

Aug 3, Epichem Completes OHD Technology Build
August 3, 2021

July 31, Top 20 Shareholders
August 1, 2021

July 30, Virtual Investor Briefing for August 12, 2021
July 30, 2021

July 28, Appendix 4C and Quarterly Update
July 28, 2021

July 26, PharmAust Update on COVID-19 Work
July 26, 2021

July 12, PharmAust and WEHI Investigate Monepantel in HTLV-1 infection
July 12, 2021

Recent Articles

Aug 3, Epichem Completes OHD Technology Build
August 3, 2021
July 31, Top 20 Shareholders
August 1, 2021
July 30, Virtual Investor Briefing for August 12, 2021
July 30, 2021
July 28, Appendix 4C and Quarterly Update
July 28, 2021

MENU

Home
About Us
Pipeline & Trials
Investor Centre
Media
Contact Us

SUBSCRIBE TO OUR NEWSLETTER

Leave this field empty if you're human:

TWITTER

PharmAustFollow

PharmAust @PharmAust·

$PAA/@PharmAust’s subsidiary @Epichem builds ‘world-first’ flow reactor to convert waste into fuel

https://stockhead.com.au/health/pharmausts-subsidiary-epichem-builds-world-first-flow-reactor-to-convert-waste-into-fuel/

Reply on Twitter 1422402739422699525 Retweet on Twitter 14224027394226995255 Like on Twitter 14224027394226995255 Twitter 1422402739422699525

Copyright © 2020 Pharmaust. All rights reserved.

Website Design & Digital Marketing Perth by Total Click Solutions